Leaders Weigh In
Shields CEO Michael Ham hailed the partnership, saying it validated the company’s health system–focused strategy.
“Our team at Shields has been proud to deliver exceptional clinical, financial and operational outcomes for our partners and their patients,” Ham said. “Both Sycamore’s acquisition of Shields, and Evernorth’s support for the transaction, demonstrate clear validation of our specialty pharmacy model.”
For Evernorth, based in St. Louis, Missouri, the investment aligns with its existing suite of services — from direct-to-patient pharmacies and distribution to home and ambulatory infusion services.
Legal Counsel Behind the Billion-Dollar Move
The Holland & Knight team, led by partner Jeffrey Mittleman, served as regulatory counsel to Evernorth.
While full details of Wachtell’s counsel team were not immediately disclosed, a Shields representative confirmed no additional law firms advised on the deal. However, Davis Polk & Wardwell advised Sycamore Partners in its Walgreens acquisition.
